Recombinant Protein Production News and Research

RSS
Developing and manufacturing custom recombinant antibodies for R&D

Developing and manufacturing custom recombinant antibodies for R&D

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services

Sino Biological Invests Over 200M RMB to Establish New Subsidiaries in Taizhou and Suzhou, China.

Sino Biological Invests Over 200M RMB to Establish New Subsidiaries in Taizhou and Suzhou, China.

Current and future perspectives of mRNA technology

Current and future perspectives of mRNA technology

Providing recombinant antibody services and more within Europe

Providing recombinant antibody services and more within Europe

Sino Biological Establishes New Location in Houston, Texas

Sino Biological Establishes New Location in Houston, Texas

Providing quick & efficient CRO services with Sino Biological

Providing quick & efficient CRO services with Sino Biological

Isolation of potent neutralizing monoclonal antibodies using nanoparticles displaying SARS-CoV-2 S glycoprotein

Isolation of potent neutralizing monoclonal antibodies using nanoparticles displaying SARS-CoV-2 S glycoprotein

Adapting biological research and development to COVID-19

Adapting biological research and development to COVID-19

New book focuses on rational drug design and discovery

New book focuses on rational drug design and discovery

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Immune responsive nanoparticles for COVID-19 vaccine delivery

Immune responsive nanoparticles for COVID-19 vaccine delivery

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

New genome-editing techniques could make recombinant-protein drugs cheaper

New genome-editing techniques could make recombinant-protein drugs cheaper

U.S. Army project may lead to new class of self-healing materials and therapeutics for soldiers

U.S. Army project may lead to new class of self-healing materials and therapeutics for soldiers

ProteoNic’s 2G UNic protein production technology licensed to Bayer

ProteoNic’s 2G UNic protein production technology licensed to Bayer

AvantGen and ACROBiosystems sign vendor agreement

AvantGen and ACROBiosystems sign vendor agreement

Immune checkpoint molecule protects against future development of cancer

Immune checkpoint molecule protects against future development of cancer

Researchers study animal venoms to identify new medicines for treating diseases

Researchers study animal venoms to identify new medicines for treating diseases